Drug-Eluting Balloons

This channel includes news and new technology innovations for drug coated balloons, also referred to as drug-eluting balloons. These are used to treat peripheral and coronary artery lesions and restenosis.

News | July 27, 2012

July 27, 2012 — C. R. Bard Inc. announced that its Lutonix technology center has completed patient enrollment into...

News | July 09, 2012

July 9, 2012 — Cardionovum GmbH announced it has initiated in vivo testing of its second...

News | June 13, 2012

June 13, 2012 — Physicians presented at EuroPCR 2012 the results of two multicenter, randomized controlled trials,...

Feature | April 17, 2012

April 17, 2012 –– Expanding its commitment to developing innovative treatments for cardiovascular disease and the...

News | March 20, 2012

March 20, 2012 - MarBlue Medical announced the global product launch of its CE-marked...

News | January 25, 2012

January 25, 2012 — Physicians at University Hospitals (UH) Case Medical Center enrolled their first patient in...

News | January 06, 2012

January 6, 2012 - C. R. Bard recently announced it acquired drug-eluting balloon maker Lutonix Inc. for $225 million...

News | December 28, 2011

December 28, 2011 – Good Samaritan Hospital in Los Angeles is participating in the Levant 2 clinical trial to...

News | November 14, 2011

November 14, 2011 — A clinical trial of patients with restenosis in drug-eluting stents (DES) in native coronary...

News | November 14, 2011

November 14, 2011 – Medrad Inc. announced that five-year data from the THUNDER trial [1] demonstrated a 59 percent...

News | September 16, 2011

September 15, 2011 – The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first...

News | September 15, 2011

September 15, 2011 — Very positive results were reported in the first account of a clinical study evaluating the...

News | July 26, 2011

July 26, 2011 – The first patient has been enrolled in the LEVANT 2 clinical trial, a global, multi-center,...

News | May 18, 2011

May 17, 2011 - Medrad Inc., a business of Bayer HealthCare, today announced it has received CE Mark for its...

News | November 17, 2010

November 17, 2010 – A drug-eluting balloon (DEB) and a coronary stent have received CE mark approval in Europe. The...

Overlay Init